ATAI Life Sciences N.V. News
Latest updates and market news for ATAI
4 news
Feb 27 - Mar 5, 2026
Page 1
Insider Monkey
AtaiBeckley Inc (ATAI)’s Drug Candidate EMP-01 Shows Positive Results in Key Study
📈
AI Sentiment
Highly Positive
8/10
Proactive
AtaiBeckley cleared for Phase 3 trials of nasal spray depression treatment after FDA backing
📈
AI Sentiment
Highly Positive
9/10
GlobeNewswire
AtaiBeckley Announces Successful End-of-Phase 2 Meeting for BPL-003 in Treatment-Resistant Depression
📈
AI Sentiment
Highly Positive
9/10
Share this news page